Gynecologic Oncology

ESMO 2024

Questions discussed in this category

What are your top takeaways in Gyn Cancers from ESMO 2024?

1 Answer available

Papers discussed in this category

J Clin Oncol, 2022 Jun 06

A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).

Annals of oncology : official journal of the European Society for Medical Oncology, 2024 Sep 14

Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial.

Related Topics in Gynecologic Oncology